BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 10575859)

  • 1. [Is flucloxacillin-induced liver damage an underreported complication?].
    Friis-Liby I; Meresaar U; Olsson KS
    Lakartidningen; 1999 Oct; 96(42):4535-6. PubMed ID: 10575859
    [No Abstract]   [Full Text] [Related]  

  • 2. Flucloxacillin-induced cholestatic liver damage.
    Bengtsson F; Florén CH; Hägerstrand I; Söderström C; Aberg T
    Scand J Infect Dis; 1985; 17(1):125-8. PubMed ID: 3992199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effects of floxacillin on the liver. 3 cases of floxacillin-induced cholestatic liver disease].
    Götell P; Lööf L
    Lakartidningen; 1987 Mar; 84(12):954-5. PubMed ID: 3573872
    [No Abstract]   [Full Text] [Related]  

  • 4. Flucloxacillin associated cholestatic hepatitis. An Australian and Swedish epidemic?
    Devereaux BM; Crawford DH; Purcell P; Powell LW; Roeser HP
    Eur J Clin Pharmacol; 1995; 49(1-2):81-5. PubMed ID: 8751026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged hepatic cholestasis after flucloxacillin therapy.
    Turner IB; Eckstein RP; Riley JW; Lunzer MR
    Med J Aust; 1989 Dec 4-18; 151(11-12):701-5. PubMed ID: 2593915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story.
    Boyd IW
    Med J Aust; 1999 Aug; 171(4):219. PubMed ID: 10494242
    [No Abstract]   [Full Text] [Related]  

  • 7. Improving drug use: a case study of events which led to changes in use of flucloxacillin in Australia.
    Roughead EE; Gilbert AL; Primrose JG
    Soc Sci Med; 1999 Mar; 48(6):845-53. PubMed ID: 10190645
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Liver damage from flucloxacillin, cloxacillin and dicloxacillin.
    Olsson R; Wiholm BE; Sand C; Zettergren L; Hultcrantz R; Myrhed M
    J Hepatol; 1992 May; 15(1-2):154-61. PubMed ID: 1506634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Flucloxacillin and cholestatic hepatitis.
    Jick H; Derby LE; Dean AD; Henry DA
    Med J Aust; 1994 Apr; 160(8):525. PubMed ID: 8170433
    [No Abstract]   [Full Text] [Related]  

  • 10. Floxacillin-induced cholestatic hepatitis with evidence of lymphocyte sensitization.
    Victorino RM; Maria VA; Correia AP; de Moura C
    Arch Intern Med; 1987 May; 147(5):987-9. PubMed ID: 3579450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibiotic-associated acute vanishing bile duct syndrome: a pattern associated with severe, prolonged, intrahepatic cholestasis.
    Davies MH; Harrison RF; Elias E; Hübscher SG
    J Hepatol; 1994 Jan; 20(1):112-6. PubMed ID: 8201211
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A case of icterus after floxacillin treatment].
    Thune A; Zackrisson B
    Lakartidningen; 1987 Mar; 84(12):955. PubMed ID: 3573873
    [No Abstract]   [Full Text] [Related]  

  • 13. Toxicities of flucloxacillin and dicloxacillin--is there really a difference?
    Gosbell IB; Turnidge JD; Tapsall JW; Benn RA
    Med J Aust; 2000 Nov; 173(9):500-1. PubMed ID: 11149309
    [No Abstract]   [Full Text] [Related]  

  • 14. Flucloxacillin hepatitis: an Australian epidemic--comment.
    Blackmore TK; Wesselingh SL; Gordon DL
    Aust N Z J Med; 1995 Oct; 25(5):537. PubMed ID: 8588780
    [No Abstract]   [Full Text] [Related]  

  • 15. Adverse hepatic events associated with drug therapy.
    Hewitt J; Hammond L
    Med J Aust; 1996 Sep; 165(6):347, 350. PubMed ID: 8862340
    [No Abstract]   [Full Text] [Related]  

  • 16. Postmarketing surveillance: strengths and limitations. The flucloxacillin-dicloxacillin story.
    McNeil JJ; Grabsch EA; McDonald MM
    Med J Aust; 1999 Mar; 170(6):270-3. PubMed ID: 10212650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Intrahepatic cholestasis induced by amoxicillin alone].
    Bolzan H; Spatola J; Castelletto R; Curciarello J
    Gastroenterol Hepatol; 2000 May; 23(5):237-9. PubMed ID: 10902278
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Flucloxacillin-induced liver injury.
    Andrews E; Daly AK
    Toxicology; 2008 Dec; 254(3):158-63. PubMed ID: 18793693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A pseudolymphomatous skin reaction secondary to flucloxacillin.
    Melzer M; Keane FM; Eykyn SJ; Breathnach SM
    J Infect; 2000 Mar; 40(2):198-9. PubMed ID: 10841103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Thrombosis caused by oracl contraceptives. Underreporting to the adverse effects registry].
    Samuelsson E; Hägg S; Bäckström M; Granberg K; Mjörndal T
    Lakartidningen; 1996 Sep; 93(37):3117-8, 3121-4. PubMed ID: 8847932
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.